Alma Gregory Sorensen
CIK 1731883 · Chief Strategy Officer · last filed 2026-03-23
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
RDNT price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
1510 COTNER AVENUE
LOS ANGELES, CA 90025
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RDNT | Chief Strategy Officer | 1,230,797 | $69.27 | $85.26M | -$8.47M | 11 | 2026-03-23 |
| AdaptHealth Corp. (AHCOW) Delisted | Director | 50,000 | — | — | $0 | 1 | 2019-11-13 |
| AdaptHealth Corp. (VTL) Delisted | Director | 1,402 | — | — | $0 | 2 | 2018-04-03 |
| MFA FINANCIAL, INC. (MFO) Delisted | Director | 60,000 | — | — | $0 | 1 | 2018-02-23 |
Recent Filings · Page 2 of 3
22 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-05-23 | RDNT | Notice (144) | −55,000 | -$3.11M | EDGAR |
| 2025-05-22 | RDNT | Notice (144) | −45,000 | -$2.57M | EDGAR |
| 2025-05-02 | RDNT | Grant (A) | +10,232 | $0 | EDGAR |
| 2025-01-10 | RDNT | Grant (A) | +11,072 | $0 | EDGAR |
| 2024-06-13 | RDNT | Sell (S) | −15,000 | -$929.6K | EDGAR |
| 2024-06-12 | RDNT | Notice (144) | −10,000 | -$623.4K | EDGAR |
| 2024-06-11 | RDNT | Notice (144) | −5,000 | -$306.2K | EDGAR |
| 2024-01-10 | RDNT | Grant (A) | +19,423 | $0 | EDGAR |
| 2019-11-13 | AdaptHealth Corp. (AHCOW) Delisted | Other (J) | −6,087 | $0 | EDGAR |
| 2018-04-03 | AdaptHealth Corp. (VTL) Delisted | Other (J) | −3,913 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.